Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Profit After Tax: 2017-2024

Historic Profit After Tax for Tonix Pharmaceuticals Holding (TNXP) over the last 8 years, with Dec 2024 value amounting to -$136.7 million.

  • Tonix Pharmaceuticals Holding's Profit After Tax fell 101.02% to -$31.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$98.0 million, marking a year-over-year increase of 30.87%. This contributed to the annual value of -$136.7 million for FY2024, which is 17.18% down from last year.
  • As of FY2024, Tonix Pharmaceuticals Holding's Profit After Tax stood at -$136.7 million, which was down 17.18% from -$116.7 million recorded in FY2023.
  • In the past 5 years, Tonix Pharmaceuticals Holding's Profit After Tax ranged from a high of -$50.5 million in FY2020 and a low of -$136.7 million during FY2024.
  • For the 3-year period, Tonix Pharmaceuticals Holding's Profit After Tax averaged around -$121.2 million, with its median value being -$116.7 million (2023).
  • Data for Tonix Pharmaceuticals Holding's Profit After Tax shows a maximum YoY crashed of 82.88% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Tonix Pharmaceuticals Holding's Profit After Tax stood at -$50.5 million in 2020, then slumped by 82.88% to -$92.3 million in 2021, then fell by 19.43% to -$110.2 million in 2022, then fell by 5.84% to -$116.7 million in 2023, then declined by 17.18% to -$136.7 million in 2024.